Cited by 481Advanced Drug Delivery SystemsNanoparticle-Based Drug DeliveryOcular Surface and Contact Lens

Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies

Open access
Mandal, Abhirup, Bisht, Rohit, Rupenthal, Ilva D., Mitra, Ashim K.·2017·Journal of Controlled Release

Abstract

Effective intraocular drug delivery poses a major challenge due to the presence of various elimination mechanisms and physiological barriers that result in low ocular bioavailability after topical application. Over the past decades, polymeric micelles have emerged as one of the most promising drug delivery platforms for the management of ocular diseases affecting the anterior (dry eye syndrome) and posterior (age-related macular degeneration, diabetic retinopathy and glaucoma) segments of the eye. Promising preclinical efficacy results from both in-vitro and in-vivo animal studies have led to their steady progression through clinical trials. The mucoadhesive nature of these polymeric micelles results in enhanced contact with the ocular surface while their small size allows better tissue penetration. Most importantly, being highly water soluble, these polymeric micelles generate clear aqueous solutions which allows easy application in the form of eye drops without any vision interference. Enhanced stability, larger cargo capacity, non-toxicity, ease of surface modification and controlled drug release are additional advantages with polymeric micelles. Finally, simple and cost effective fabrication techniques render their industrial acceptance relatively high. This review summarizes structural frameworks, methods of preparation, physicochemical properties, patented inventions and recent advances of these micelles as effective carriers for ocular drug delivery highlighting their performance in preclinical studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jconrel.2017.01.012

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [11]Ahuja M Dhake AS Sharma SK Majumdar DK Topical ocular delivery of NSAIDs AAPS J 2008 10 229 241 18437583 PMC2751374
  2. [50]Tadros TF Microemulsions Applied Surfactants 2005 Wiley-VCH Verlag GmbH & Co. KGaA 309 334
  3. [134]SARL OT Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca (Emerald) ClinicalTrials.gov 2016 Bethesda (MD) National Library of Medicine (US)

Cited by

Sorted by citations

Authors
Mandal, A., Bisht, R., Rupenthal, I. D., & Mitra, A. K.
Affiliations
  • University of Missouri–Kansas City (US)
  • University of Auckland (NZ)
Corresponding author
Mitra, Ashim K.
Venue
Journal of Controlled Release
Publisher
Elsevier BV
Published
2017-02
Volume
248
Pages
96-116
ISSN
0168-3659 (ISSN-L)
OpenAlex
W2575367849
Cited by
481
References
148
Citations by year
2026: 32 · 2025: 47 · 2024: 58 · 2023: 80 · 2022: 61 · 2021: 64 · 2020: 45 · 2019: 46 · 2018: 29 · 2017: 19
FWCI
3.93
Type
journal article
Language
en
Open access
Locations
  • Journal of Controlled Release (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
NIH (R01 EY09171-14, NIH R01 EY10659-12)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ocular Surface and Contact Lens
Keywords
polymeric micelles, ocular drug delivery, intraocular drug delivery, dry eye, age-related macular degeneration, diabetic retinopathy, glaucoma, mucoadhesion, eye drops, controlled drug release, physicochemical properties, preclinical research, patents
MeSH terms
Animals, Biological Availability, Drug Carriers, Pharmaceutical Preparations, Eye, Eye Diseases, Humans, Micelles, Ophthalmic Solutions, Polymers, Solubility, Dry Eye Syndromes, Drug Delivery Systems, Administration, Ophthalmic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review